Results 131 to 140 of about 60,074 (286)

Quality of Life and Return to Work After Radiotherapy in Young Adults With Head‐and‐Neck Cancer—A Bicentric Cross‐Sectional Observational Study

Cancer Medicine, Volume 15, Issue 1, January 2026.
Quality of life comparison between surviving young adults with head‐and‐neck cancer who did return to work versus adults who did not return to work. ABSTRACT Objective Young adults (18–45 years) with head‐and‐neck cancer represent a unique population with limited data on quality of life (QoL) and return‐to‐work after radiotherapy.
Charlotte Pannenbecker, Clemens Seidel, Jiadai Zou, Daniel Schnell, Gunnar Wichmann, Christoph Becker, Sabine Klagges, Henning Schäfer, Andreas Knopf, Andreas Dietz, Anca‐Ligia Grosu, Anja Mehnert‐Theuerkauf, Nils H. Nicolay, Alexander Rühle   +13 more
wiley   +1 more source

A global review of acupuncture and moxibustion recommendations in guidelines/expert consensus for chemotherapy- and/or radiotherapy-induced nausea and/or vomiting

World Journal of Acupuncture - Moxibustion
Objective: To summarize and analyze the recommendations of acupuncture and moxibustion in the global guidelines/expert consensus of chemotherapy- and/or radiotherapy-induced nausea and/or vomiting, providing a basis for the development of clinical ...
Tian-yu MING, Wei-juan GANG, Lan-jun SHI, Zhen LUO, Zi-yu TIAN, Xiao-yi HU, Huan CHEN, Rui-min JIAO, Wen-cui XIU, Xiang-yu HU, Xiang-hong JING   +10 more
doaj   +1 more source

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. [PDF]

, 2000
A randomized, multicentre, open-label, phase II study compared temozolomide (TMZ), an oral second-generation alkylating agent, and procarbazine (PCB) in 225 patients with glioblastoma multiforme at first relapse.
Albright, RE, Brada, M, Bruner, J, Fink, K, Fredericks, R, Friedman, H, Glantz, M, Greenberg, H, Hohl, RJ, Levin, VA, Olson, J, Osoba, D, Phillips, P, Prados, MD, Rampling, R, Selker, RG, Shapiro, W, Spence, A, Vick, NA, Yue, N, Yung, WK, Zaknoen, S   +21 more
core  

Comparison of antiemetic efficacy and safety of palonosetron vs ondansetron in the prevention of chemotherapy-induced nausea and vomiting in children [PDF]

, 2015
Veerendra Patil, Harsha Prasada, Krishna Prasad, Udyavar Shenoy   +3 more
openalex   +1 more source

If treating obesity with GLP‐1‐based therapies protects the heart, could it also prevent cancer or improve cancer outcomes? The case for randomized trials

Diabetes, Obesity and Metabolism, EarlyView.
Anastasios Tentolouris, Ioannis Ntanasis‐Stathopoulos   +1 more
wiley   +1 more source

Mucoadhesive Polyvinyl Alcohol Film Containing Fridericia chica Extract for Mucositis Treatment: Pharmacological Evaluation and Active Compounds Release

Chemistry &Biodiversity, Volume 23, Issue 1, January 2026.
ABSTRACT Oral mucositis is a frequent and painful complication of cancer therapy with limited effective options. This study evaluated a mucoadhesive polyvinyl alcohol (PVA) film containing 2.5% Fridericia chica extract as a novel strategy. The formulation was characterized for antioxidant activity, phenolic and flavonoid content, and reactive species ...
Ilza Maria de Oliveira Sousa, Ailane Souza de Freitas, Fabrício de Faveri Favero, Lucia Elaine O. Braga, Mariana Cecchetto Figueiredo, Diana Pinto, Maria Beatriz P. P. Oliveira, Simone Nataly Busato de Feiria, Nubia de Cássia Almeida Queiroz, Ana Lucia T. G. Ruiz, José Francisco Hofling, João Ernesto de Carvalho, Mary Ann Foglio   +12 more
wiley   +1 more source

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics

Cancer Management and Research, 2016
Megan Brafford May,1 Ashley E Glode2 1Department of Pharmacy, Baptist Health Lexington, Lexington, KY, USA; 2Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus ...
May MB, Glode AE
doaj  

Safety and Efficacy Findings From a Phase Ib/II Study of ASP‐1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Head &Neck, Volume 48, Issue 1, Page 160-174, January 2026.
ABSTRACT Background ASP‐1929 photoimmunotherapy—cetuximab conjugated to IRDye 700DX and red light (690 nm) for localized drug activation—results in rapid, selective cell killing. Methods This phase Ib/II open‐label study evaluated ASP‐1929 photoimmunotherapy plus pembrolizumab in patients with recurrent/metastatic HNSCC (≥ 1 accessible lesion, PD‐L1 ...
David M. Cognetti, Joseph M. Curry, Jennifer Johnson, Michael Kwon, Shirley Y. Su, Francisco Civantos, Coral Olazagasti, Joseph Valentino, Susanne M. Arnold, R. Bryan Bell, Michael K. Gibson, Kyle Mannion, Kathryn M. Van Abel, Katharine A. Price, Haiying Dong, Amy H. Thorne, Toshiaki Suzuki, Ann M. Gillenwater   +17 more
wiley   +1 more source

A Rational Approach to Pharmacotherapy in Pregnancy

The Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Most pregnant individuals are exposed to at least one medication, whether prescription or over the counter, during pregnancy. Despite the ubiquity of medication use in pregnancy, there remains no standardized framework to guide clinicians in selecting the most appropriate pharmacotherapy that balances maternal needs with fetal safety. This gap
Gregory W. Kirschen, Kevin Watt, Ahizechukwu C. Eke   +2 more
wiley   +1 more source

Melanoma: Pathogenesis and Targeted Therapy

MedComm, Volume 7, Issue 1, January 2026.
The treatment landscape for advanced melanoma has evolved significantly. BRAF–MEK inhibitor combinations are standard for BRAF‐mutant melanoma, whereas targeting NRAS mutations is more challenging, with MEK inhibitors like tunlametinib emerging as an option.
Yang Fu, Jie Liu, Zeming Mo, Bin Wang, Yaotiao Deng, Yu Jiang   +5 more
wiley   +1 more source